Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro

Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery
Mario J J ScheurerRoman C Brands

Abstract

Head and neck cancer, which predominantly arises from the oral mucosa, represents the sixth most common malignancy worldwide. These cancer cells can be resistant to programmed cell death triggered by extrinsic stimuli due to innate overexpression of inhibitor of apoptosis proteins (IAPs). The cellular protein second mitochondria-derived activator of caspases (SMAC) can antagonize IAP-induced caspase inhibition and thus trigger apoptosis. Here, we investigate the cell death-sensitizing effects of the SMAC mimetic LCL161 alone and in combination with Fas ligand (FasL) using a panel of six cell lines. Fas receptor (FasR) expression was analyzed by flow cytometry. Cells were treated with FasL and LCL161 alone or in combination, and cytotoxicity was measured using crystal violet assays. Annexin V and cell viability assays using zVAD-fmk and Necrostatin-1 (Nec-1) were carried out to assess the type of programmed cell death induced by LCL161. To demonstrate the sensitizing effects of LCL161, we employed the t-test to compare the effects of FasL alone and in combination with LCL161. Linear regression analysis was performed to determine initial and half maximal inhibitory concentrations (IC10 and IC50, respectively). Distinct FasR expre...Continue Reading

References

Apr 1, 1993·Journal of Virology·N E CrookL K Miller
Feb 17, 1999·Genes & Development·Q L Deveraux, J C Reed
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·G D WilsonS M Bentzen
Jul 6, 2002·Pain·Ronald J Tallarida
Mar 24, 2005·Cancer Metastasis Reviews·Lajos Döbrossy
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Oct 9, 2007·Journal of Cancer Research and Clinical Oncology·Xiuguo LiXinyong Luan
Nov 21, 2007·Cell·Hao WuSu-Chang Lin
Jul 16, 2008·International Journal of Oral and Maxillofacial Surgery·S QiK Omura
Oct 22, 2008·Oncogene·E C LaCasseR G Korneluk
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Shlok GuptaWilliam J Mackillop
Jun 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sean L PetersenXiaodong Wang
Jul 20, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Zakir KhanPrakash S Bisen
Jul 24, 2010·Nature Reviews. Cancer·Mads Gyrd-Hansen, Pascal Meier
Sep 8, 2010·Cancer Letters·Dwayne G Stupack
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 5, 2012·The New England Journal of Medicine·Antoni Ribas
Oct 12, 2012·Journal of Mammary Gland Biology and Neoplasia·Shaomeng WangHaiying Sun
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jun 19, 2013·Biochimica Et Biophysica Acta·Vassiliki NikoletopoulouNektarios Tavernarakis
Oct 31, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qin QinXinchen Sun
May 6, 2014·Oral and Maxillofacial Surgery Clinics of North America·Nadarajah Vigneswaran, Michelle D Williams
May 21, 2014·Pharmacology & Therapeutics·Longchuan BaiShaomeng Wang
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey R InfanteRoger B Cohen
Jan 1, 2015·Seminars in Cell & Developmental Biology·Simone Fulda
Jan 17, 2015·Nature·Manolis Pasparakis, Peter Vandenabeele
Sep 4, 2015·Molecular Cancer Therapeutics·Ravi K AmaravadiAlex A Adjei
Sep 24, 2015·The FEBS Journal·Andrew Oberst
Jan 24, 2016·Biochimica Et Biophysica Acta·Zhentai HuangHülya Bayır
Feb 6, 2016·Clinical Oral Investigations·Roman C BrandsUrs D A Müller-Richter
Apr 15, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony TolcherJeffrey R Infante
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Oct 16, 2016·Journal of Experimental & Clinical Cancer Research : CR·Chengcheng YangSida Qin
May 23, 2017·Oncology Research and Treatment·Adriana Jou, Jochen Hess

❮ Previous
Next ❯

Citations

Jul 1, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nir Shahar, Sarit Larisch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis